Biontech Se Adr (BNTX)

Dec 19, 2024

BioNTech SE ADR falls Thursday, underperforms market - MarketWatch

Dec 19, 2024

Dec 18, 2024

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

Dec 18, 2024

Dec 18, 2024

3 No-Brainer Biotech Stocks to Buy With $200 Right Now - The Motley Fool

Dec 18, 2024

Dec 18, 2024

Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily

Dec 18, 2024

Dec 17, 2024

BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch

Dec 17, 2024

Dec 16, 2024

BioNTech SE ADR falls Monday, underperforms market - MarketWatch

Dec 16, 2024

Dec 16, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com

Dec 16, 2024

Dec 13, 2024

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

Dec 13, 2024

Dec 12, 2024

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

Dec 12, 2024

Dec 11, 2024

BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch

Dec 11, 2024

Dec 10, 2024

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

Dec 10, 2024

Dec 06, 2024

BioNTech SE ADR rises Friday, outperforms market - MarketWatch

Dec 06, 2024

Dec 03, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock balances COVID legacy, oncology future - Investing.com

Dec 03, 2024

Nov 25, 2024

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

Nov 25, 2024

Nov 25, 2024

Stocks Showing Improving Market Leadership: BioNTech ADR Earns 81 RS Rating - Investor's Business Daily

Nov 25, 2024

Nov 22, 2024

BioNTech ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily

Nov 22, 2024

Nov 21, 2024

BioNTech's SWOT analysis: oncology pipeline fuels stock's potential amid market volatility - Investing.com

Nov 21, 2024

Nov 20, 2024

BioNTech Stock Got A IBD RS Rating Lift - MSN

Nov 20, 2024

Nov 20, 2024

BioNTech ADR Shows Improved Relative Strength; Still Shy Of Benchmark - Inkl

Nov 20, 2024

Nov 19, 2024

Analysts Turn Bullish on BioNTech Stock Amid Volatility - Schaeffers Research

Nov 19, 2024

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 16, 2024

BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register

Nov 16, 2024

Nov 15, 2024

Powell Speaks The Truth - Benzinga

Nov 15, 2024

Nov 15, 2024

Goodwin, Conyers, A&O Shearman Act on $800M China Biotech Sale - Law.com International

Nov 15, 2024

Nov 14, 2024

BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up - Yahoo Finance

Nov 14, 2024

Nov 08, 2024

Stock Futures Quiet as Market Heads for Winning Week - Schaeffers Research

Nov 08, 2024

Nov 05, 2024

BioNTech Earnings: Strong Covid Revenue, but Full-Year Expectations Unchanged - Morningstar

Nov 05, 2024

Nov 04, 2024

BioNTech SE Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024

Nov 04, 2024

This 6%-yielding U.S. pharma giant is a safe hold - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024

Oct 31, 2024

BioNTech SE ADR outperforms market despite losses on the day - MarketWatch

Oct 31, 2024

Oct 29, 2024

Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase - Yahoo Finance

Oct 29, 2024

Oct 28, 2024

Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - Nasdaq

Oct 28, 2024

Oct 28, 2024

BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - MSN

Oct 28, 2024